Simulations Plus, Inc. (NASDAQ:SLP) Stock Now Rated “Reduce” by Sell-Side Brokerages

Simulations Plus, Inc. (NASDAQ:SLP) has been assigned an average rating of “Reduce” from the eight ratings firms that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating and seven have given a hold rating to the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $17.25.

A number of research firms have commented on SLP. Weiss Ratings raised shares of Simulations Plus from a “sell (d)” rating to a “sell (d+)” rating in a research note on Friday, July 10th. Craig Hallum lowered shares of Simulations Plus from a “buy” rating to a “hold” rating and set a $18.50 price target on the stock. in a report on Thursday, June 18th. Wall Street Zen lowered shares of Simulations Plus from a “buy” rating to a “hold” rating in a report on Saturday, June 13th. Finally, William Blair lowered shares of Simulations Plus from an “outperform” rating to a “market perform” rating in a research note on Wednesday, June 17th.

Institutional Trading of Simulations Plus

A number of hedge funds have recently modified their holdings of the business. GAMMA Investing LLC grew its stake in Simulations Plus by 26.0% during the 2nd quarter. GAMMA Investing LLC now owns 2,831 shares of the technology company’s stock valued at $52,000 after acquiring an additional 585 shares in the last quarter. Bank of New York Mellon Corp increased its holdings in shares of Simulations Plus by 1.3% in the 1st quarter. Bank of New York Mellon Corp now owns 63,592 shares of the technology company’s stock valued at $752,000 after purchasing an additional 844 shares during the period. Integrated Wealth Concepts LLC purchased a new stake in shares of Simulations Plus in the second quarter worth approximately $26,000. Hsbc Holdings PLC lifted its position in shares of Simulations Plus by 6.1% in the second quarter. Hsbc Holdings PLC now owns 28,116 shares of the technology company’s stock worth $520,000 after purchasing an additional 1,622 shares in the last quarter. Finally, PNC Financial Services Group Inc. boosted its holdings in shares of Simulations Plus by 59.3% during the first quarter. PNC Financial Services Group Inc. now owns 4,485 shares of the technology company’s stock worth $53,000 after purchasing an additional 1,669 shares during the period. Hedge funds and other institutional investors own 78.08% of the company’s stock.

Simulations Plus Price Performance

Shares of Simulations Plus stock opened at $18.48 on Friday. The stock’s fifty day moving average is $18.38 and its 200-day moving average is $16.39. The firm has a market capitalization of $373.85 million, a PE ratio of 46.20 and a beta of 1.33. Simulations Plus has a 12-month low of $11.09 and a 12-month high of $21.01.

Simulations Plus (NASDAQ:SLP) last released its quarterly earnings results on Thursday, July 9th. The technology company reported $0.30 earnings per share for the quarter, beating analysts’ consensus estimates of $0.23 by $0.07. The business had revenue of $21.89 million during the quarter, compared to analyst estimates of $20.90 million. Simulations Plus had a return on equity of 13.50% and a net margin of 9.88%.

About Simulations Plus

Simulations Plus, Inc develops software and provides consulting services for pharmaceutical and biotechnology companies involved in drug discovery and development. Its modeling and simulation tools are designed to help researchers evaluate drug candidates, understand how medicines move through the body, assess safety risks and support decisions throughout the development process.

The company’s products include GastroPlus, a platform used for physiologically based pharmacokinetic and biopharmaceutic modeling; ADMET Predictor, which helps predict absorption, distribution, metabolism, excretion and toxicity characteristics; and DILIsym, a software platform focused on drug-induced liver injury.